Burden of female breast and five gynecological cancers in China and worldwideOACSTPCDMEDLINE
Background:Female breast and five gynecological cancers remain substantial burden in China and worldwide.GLOBOCAN 2022 has recently updated the estimates of cancer burden.This study aims to depict the profiles of disease burd…查看全部>>
Nuopei Tan;You Wu;Bin Li;Wanqing Chen
Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Gynecology Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Gynecology Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaOffice of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
临床医学
Cancer incidenceCancer mortalityChinaGLOBOCANWorldwideFemale organBreast cancerOvarian cancer
《Chinese Medical Journal》 2024 (18)
P.2190-2201,12
supported by the special research fund for central universities,Peking Union Medical College(No.3332023025)
评论